| Trial ID: | L7102 |
| Source ID: | NCT00308347
|
| Associated Drug: |
Mk0954, Losartan / Duration Of Treatment: Mean 3.4 Years
|
| Title: |
A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Nephropathy
|
| Interventions: |
DRUG: MK0954, losartan / Duration of Treatment: mean 3.4 years|DRUG: Placebo / Duration of Treatment: mean 3.4 years
|
| Outcome Measures: |
Primary: Combined endpoint of doubling of serum creatinine, ESRD or death. | Secondary: Secondary parameters: number of cardiovascular events and changes in proteinuria. Tertiary parameters: quality of life and healthcare resource utilization.
|
| Sponsor/Collaborators: |
Sponsor: Organon and Co
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
1513
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
1996-05
|
| Completion Date: |
2001-04
|
| Results First Posted: |
|
| Last Update Posted: |
2022-02-15
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00308347
|
